Xue-Feng Shan

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Emergency Department

Immune Response

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Feng-Li Xu, Xiao-Hong Wu, Chang Chen, Kai Wang, Lu-Yi Huang, Jie Xia, Yi Liu, Xue-Feng Shan, Ni Tang
SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase. Cell death & disease 14 (1) (2023)
Feng-Li Xu, Xiao-Hong Wu, Chang Chen, Kai Wang, Lu-Yi Huang, Jie Xia, Yi Liu, Xue-Feng Shan, Ni Tang
SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase. Cell death & disease 14 (1) (2023)
Feng-Li Xu, Xiao-Hong Wu, Chang Chen, Kai Wang, Lu-Yi Huang, Jie Xia, Yi Liu, Xue-Feng Shan, Ni Tang
SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase. Cell death & disease 14 (1) (2023)
Feng-Li Xu, Xiao-Hong Wu, Chang Chen, Kai Wang, Lu-Yi Huang, Jie Xia, Yi Liu, Xue-Feng Shan, Ni Tang
SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase. Cell death & disease 14 (1) (2023)